Polycythemia Vera Study Group (PVSG) Diagnostic Criteria for Essential Thrombocytopaenia (ET)
All of the following criteria must be fulfilled to make a diagnosis of ET
-
Platelet count greater than 600 x 109/L
-
Hematocrit less than 40 or normal red blood cell mass
-
Stainable iron in the marrow or normal RBC mean corpuscular volume (If these measurements suggest iron deficiency, polycythemia vera cannot be excluded unless a trial of iron therapy fails to increase the red blood cell mass into the polycythemic range.)
-
No Philadelphia chromosome or bcr/abl gene rearrangement
-
Collagen fibrosis of the bone marrow absent or less than one third of the biopsy area without both marked splenomegaly and a leukoerythroblastic blood film
-
No cytogenetic or morphologic evidence for a myelodysplastic syndrome
-
No cause for a reactive thrombocytosis
WHO Diagnostic Criteria for Essential Thrombocytopaenia (ET)
Positive criteria
- Sustained platelet count > 600x 109/l
- Bone marrow biopsy specimen showing proliferation mainly of the megakaryocytic lineage with increased numbers of enlarged, mature megakaryocytes
Criteria of exclusion
- No evidence of polycythaemia vera (PV)
- Normal red cell mass or Hb <18.5 g/dl in men, 16.5g/dl in women
- Stainable iron in marrow, normal serum ferritin or normal mean corpuscular volume (MCV)
- If the former is not met, failure of iron trial to increase red cell mass or hemoglobin levels to the PV range
- No evidence of CML
- No evidence of Philadelphia chromosome and no BCR/ABL fusion gene
- No evidence of idiopathic myelofibrosis
- Collagen fibrosis absent
- Reticulin fibrosis minimal or absent
- No evidence of myelodysplastic syndrome
- No del(5q), t(3;3)(q21;26), inv(3)(q21q26)
- No significant granulocytic dysplasia; few, if any, micromegakaryocytes
- No evidence that thrombocytosis is reactive due to:
- Underlying inflammation or infection
- Underlying neoplasm
- Prior splenectomy
References:
- Imbert M, Pierre R, Thiele J, Vardiman JW, Brunning RD, Flandrin G. Essential thrombocythaemia. In: Jaffe ES, Harris NL, Stein H, et al, editors. WHO classification of tumours: tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 39-41.
- Murphy S, Peterson P, Iland H, Laszlo J. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Semin Hematol. 1997 Jan;34(1):29-39. [Medline]
- Harrison CN, Green AR. Essential thrombocythemia. Hematol Oncol Clin North Am. 2003 Oct;17(5):1175-90, vii. [Medline]
Created: Sep 03, 2007